3 ms·
This set off my "potential misinformation" alarms, and still seems a little unusual to me, but there is a supporting press release[1] on FDA.gov about a medicat
by jka 5y ago
This set off my "potential misinformation" alarms, and still seems a little unusual to me, but there is a supporting press release[1] on FDA.gov about a medication (named "Abilify MyCite") that fits the description.
Quoting selectively from the press release:
> It is important to note that Abilify MyCite’s prescribing information (labeling) notes that the ability of the product to improve patient compliance with their treatment regimen has not been shown.
[1] - https://www.fda.gov/news-events/press-announcements/fda-approves-pill-sensor-digitally-tracks-if-patients-have-ingested-their-medication https://www.fda.gov/news-events/press-announcements/fda-appr...